Indinavir sulfate NEW
| Price | $34 |
| Package | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-15 |
Product Details
| Product Name: Indinavir sulfate | CAS No.: 157810-81-6 |
| Purity: 99.95% | Supply Ability: 10g |
| Release date: 2026/06/15 |
Product Introduction
Bioactivity
| Name | Indinavir sulfate |
| Description | Indinavir sulfate (L735524 sulfate) is a HIV protease inhibitor.It inhibits the HIV-1 protease with an IC50 value of 0.41 nM and Ki value of 0.24 nM. |
| In vitro | At low concentrations (0.0003-10?μmol/l) indinavir acts as a positive allosteric modulator (EC50?=?0.021?μmol/l), whereas at concentrations greater than 10?μmol/l (30-100?μmol/l) indinavir acts as an inhibitor of the α7-nicotinic acetylcholine receptor. |
| Storage | Store at low temperature,Store under nitrogen Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : 10 mg/mL (14.05 mM), Solution. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 4 mg/mL (5.62 mM), Sonication is recommended. DMSO : 125 mg/mL (175.59 mM), Sonication is recommended. |
| Keywords | SARS-CoV | SARSCoV | SARS coronavirus | PBMC | MMP | MK-639 Sulfate | MK639 Sulfate | MK-639 | MK639 | MK 639 Sulfate | MK 639 | Matrix metalloproteinases | L-735524 Sulfate | L735524 Sulfate | L-735524 | L735524 | L 735524 Sulfate | L 735524 | Inhibitor | inhibit | Indinavir sulfate | Indinavir | Human immunodeficiency virus | Huh7 | HIVProtease | HIV Protease | HIV | hepatocarcinomas | CD4 T cells | Apoptosis |
| Inhibitors Related | Stavudine | Aceglutamide | Emtricitabine | Urea | Tamoxifen | Hydroxychloroquine | Lamivudine | Metronidazole | Doxycycline | Formamide | Alginic acid | Sildenafil citrate |
| Related Compound Libraries | Bioactive Compound Library | Pediatric Drug Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 | |
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-13 | ||
| $1.00 |
VIP7Y
|
Career Henan Chemical Co
|
2019-12-24 | |
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-02 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY